Biotechnology
The Biotechnology industry has a total of 606 stocks, with a combined market cap of $1.1 trillion and total revenue of $105.22 billion.
Market Cap
1.1T
Revenue
105.22B
Profits
-42.54B
PE Ratio
n/a
Profit Margin
-40.43%
Dividend Yield
0.04%
606 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.88B | -1.14% | 989,343 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 71.06B | -1.52% | 604,447 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 54.85B | -3.44% | 1,607,511 | 3.21B |
| 4 | ARGX | argenx SE | 54.73B | -1.26% | 331,852 | 3.68B |
| 5 | INSM | Insmed Incorporated | 41.41B | -1.21% | 2,347,060 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 35.27B | -2.39% | 307,379 | 4.97B |
| 7 | BNTX | BioNTech SE | 23.05B | -1.47% | 1,550,062 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 21.99B | -1.50% | 5,257,898 | 2.35B |
| 9 | GMAB | Genmab A/S | 19.29B | -3.16% | 1,047,299 | 3.85B |
| 10 | INCY | Incyte Corporation | 18.68B | -1.59% | 2,455,685 | 4.81B |
| 11 | RVMD | Revolution Medicines, Inc. | 15.04B | -2.81% | 2,264,836 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 14.21B | -2.67% | 4,438,060 | 20.33M |
| 13 | BBIO | BridgeBio Pharma, Inc. | 13.81B | -3.46% | 1,709,187 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 13.12B | -8.64% | 4,013,071 | - |
| 15 | IONS | Ionis Pharmaceuticals, Inc. | 12.77B | -3.25% | 1,866,196 | 966.96M |
| 16 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.58B | -2.58% | 279,706 | 740.64M |
| 17 | ASND | Ascendis Pharma A/S | 12.01B | -5.06% | 894,528 | 758.59M |
| 18 | EXEL | Exelixis, Inc. | 11.27B | -0.71% | 2,890,315 | 2.29B |
| 19 | MRNA | Moderna, Inc. | 11.03B | 0.97% | 11,701,373 | 2.23B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.74B | 0.06% | 2,889,704 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.32B | 0.83% | 2,265,832 | 3.09B |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 9.86B | -3.95% | 1,172,347 | 4.16B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.35B | 0.34% | 5,713,602 | 829.45M |
| 24 | ABVX | ABIVAX Société Anonyme | 9.24B | 6.94% | 2,708,121 | 7.07M |
| 25 | TECH | Bio-Techne Corporation | 9.16B | -2.44% | 1,835,889 | 1.22B |
| 26 | CORT | Corcept Therapeutics Incorporated | 8.75B | 0.20% | 887,706 | 741.17M |
| 27 | NUVL | Nuvalent, Inc. | 8.16B | -2.58% | 478,061 | - |
| 28 | CAI | Caris Life Sciences, Inc. | 7.66B | -4.27% | 2,397,895 | 649.06M |
| 29 | CYTK | Cytokinetics, Incorporated | 7.53B | -3.95% | 1,710,809 | 87.21M |
| 30 | AXSM | Axsome Therapeutics, Inc. | 7.32B | -1.59% | 439,991 | 561.26M |
| 31 | MRUS | Merus N.V. | 7.31B | 0.09% | 1,370,506 | 56.61M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 7.28B | -1.61% | 1,592,237 | 1.24B |
| 33 | CDTX | Cidara Therapeutics, Inc. | 6.93B | 0.10% | 872,038 | 302.00K |
| 34 | KRYS | Krystal Biotech, Inc. | 6.80B | 0.25% | 369,575 | 373.16M |
| 35 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.72B | -4.25% | 678,635 | 174.33M |
| 36 | PRAX | Praxis Precision Medicines, Inc. | 6.46B | -4.74% | 597,788 | 7.46M |
| 37 | KYMR | Kymera Therapeutics, Inc. | 6.25B | -7.87% | 2,339,154 | 43.74M |
| 38 | PTCT | PTC Therapeutics, Inc. | 5.90B | -4.47% | 1,295,497 | 1.78B |
| 39 | COGT | Cogent Biosciences, Inc. | 5.86B | -4.39% | 2,430,313 | - |
| 40 | PCVX | Vaxcyte, Inc. | 5.86B | -3.14% | 1,016,847 | - |
| 41 | PTGX | Protagonist Therapeutics, Inc. | 5.54B | -1.87% | 1,439,973 | 209.22M |
| 42 | CRSP | CRISPR Therapeutics AG | 5.44B | -0.56% | 2,168,874 | 38.34M |
| 43 | BLTE | Belite Bio, Inc | 5.20B | -0.52% | 246,487 | - |
| 44 | APGE | Apogee Therapeutics, Inc. | 5.04B | -1.77% | 916,608 | - |
| 45 | CELC | Celcuity Inc. | 4.75B | -1.27% | 904,514 | - |
| 46 | ADMA | ADMA Biologics, Inc. | 4.71B | 2.11% | 2,631,010 | 488.56M |
| 47 | SRRK | Scholar Rock Holding Corporation | 4.55B | -1.37% | 1,426,106 | - |
| 48 | ACAD | ACADIA Pharmaceuticals Inc. | 4.55B | 0.49% | 1,910,010 | 1.05B |
| 49 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.55B | 1.05% | 1,174,998 | 1.54M |
| 50 | AKRO | Akero Therapeutics, Inc. | 4.50B | 0.09% | - | - |
| 51 | TGTX | TG Therapeutics, Inc. | 4.45B | -1.30% | 983,279 | 531.90M |
| 52 | LEGN | Legend Biotech Corporation | 4.41B | -8.58% | 5,378,107 | 909.05M |
| 53 | VKTX | Viking Therapeutics, Inc. | 4.21B | -1.84% | 1,692,309 | - |
| 54 | CNTA | Centessa Pharmaceuticals plc | 4.18B | -3.02% | 938,024 | 15.00M |
| 55 | ACLX | Arcellx, Inc. | 4.10B | -4.37% | 1,549,441 | 35.90M |
| 56 | GPCR | Structure Therapeutics Inc. | 4.05B | -4.63% | 3,698,395 | - |
| 57 | IMVT | Immunovant, Inc. | 3.99B | -1.77% | 1,052,155 | - |
| 58 | NAMS | NewAmsterdam Pharma Company N.V. | 3.95B | -2.66% | 956,958 | 35.24M |
| 59 | TERN | Terns Pharmaceuticals, Inc. | 3.83B | 5.82% | 9,280,663 | - |
| 60 | ARQT | Arcutis Biotherapeutics, Inc. | 3.65B | -4.09% | 2,144,822 | 317.93M |
| 61 | WVE | Wave Life Sciences Ltd. | 3.56B | 15.06% | 37,971,274 | 109.23M |
| 62 | RARE | Ultragenyx Pharmaceutical Inc. | 3.50B | -0.41% | 2,409,203 | 630.60M |
| 63 | IRON | Disc Medicine, Inc. | 3.46B | -0.61% | 423,037 | - |
| 64 | OCUL | Ocular Therapeutix, Inc. | 3.40B | -0.99% | 5,014,014 | 55.78M |
| 65 | TARS | Tarsus Pharmaceuticals, Inc. | 3.38B | -3.26% | 551,839 | 366.10M |
| 66 | CGON | CG Oncology, Inc. | 3.37B | -2.48% | 842,759 | 2.17M |
| 67 | XENE | Xenon Pharmaceuticals Inc. | 3.36B | -2.27% | 514,253 | 7.50M |
| 68 | MIRM | Mirum Pharmaceuticals, Inc. | 3.36B | -3.68% | 991,877 | 471.79M |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.23B | -0.52% | 105,746 | 664.23M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.10B | -2.83% | 1,513,649 | 240.00M |
| 71 | TVTX | Travere Therapeutics, Inc. | 3.09B | 0.64% | 1,184,373 | 435.83M |
| 72 | VRDN | Viridian Therapeutics, Inc. | 3.04B | -0.25% | 1,989,670 | 70.79M |
| 73 | FOLD | Amicus Therapeutics, Inc. | 3.03B | -0.41% | 3,614,399 | 598.70M |
| 74 | APLS | Apellis Pharmaceuticals, Inc. | 3.01B | -0.04% | 1,839,971 | 1.02B |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 2.99B | -3.57% | 1,028,664 | 214.83M |
| 76 | LQDA | Liquidia Corporation | 2.96B | -2.77% | 948,666 | 69.22M |
| 77 | MLYS | Mineralys Therapeutics, Inc. | 2.91B | -3.85% | 1,245,098 | - |
| 78 | DNLI | Denali Therapeutics Inc. | 2.88B | -0.15% | 1,356,015 | - |
| 79 | VERA | Vera Therapeutics, Inc. | 2.86B | -0.82% | 1,769,303 | - |
| 80 | AAPG | Ascentage Pharma Group International | 2.80B | -3.99% | 2,308 | 54.52M |
| 81 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.77B | -2.63% | 1,106,704 | 578.20M |
| 82 | NUVB | Nuvation Bio Inc. | 2.74B | -6.76% | 5,915,915 | 26.75M |
| 83 | SLNO | Soleno Therapeutics, Inc. | 2.69B | -2.29% | 900,346 | 98.68M |
| 84 | DYN | Dyne Therapeutics, Inc. | 2.63B | -16.94% | 6,355,172 | - |
| 85 | BEAM | Beam Therapeutics Inc. | 2.61B | -2.29% | 1,117,381 | 55.70M |
| 86 | SYRE | Spyre Therapeutics, Inc. | 2.61B | -2.74% | 830,162 | - |
| 87 | RXRX | Recursion Pharmaceuticals, Inc. | 2.49B | -1.04% | 17,737,725 | 43.69M |
| 88 | EWTX | Edgewise Therapeutics, Inc. | 2.47B | -0.93% | 1,103,673 | - |
| 89 | MESO | Mesoblast Limited | 2.41B | 3.59% | 314,561 | 17.20M |
| 90 | SRPT | Sarepta Therapeutics, Inc. | 2.32B | 1.42% | 2,223,202 | 2.41B |
| 91 | ADPT | Adaptive Biotechnologies Corporation | 2.27B | -0.60% | 3,453,020 | 252.75M |
| 92 | HRMY | Harmony Biosciences Holdings, Inc. | 2.24B | -0.26% | 920,066 | 825.94M |
| 93 | IBRX | ImmunityBio, Inc. | 2.19B | -1.77% | 8,504,693 | 82.56M |
| 94 | OLMA | Olema Pharmaceuticals, Inc. | 2.09B | -5.00% | 2,458,516 | - |
| 95 | GLPG | Galapagos NV | 2.09B | 0.44% | 66,352 | 336.64M |
| 96 | ZLAB | Zai Lab Limited | 2.08B | -1.84% | 801,068 | 441.63M |
| 97 | ZBIO | Zenas BioPharma, Inc. | 2.05B | -2.77% | 224,132 | 15.00M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.05B | -0.96% | 1,082,146 | 265.81M |
| 99 | NRIX | Nurix Therapeutics, Inc. | 1.98B | -8.94% | 2,881,944 | 83.69M |
| 100 | MAZE | Maze Therapeutics, Inc. | 1.96B | -1.69% | 289,837 | 2.50M |
| 101 | VCEL | Vericel Corporation | 1.94B | 2.90% | 1,045,430 | 258.72M |
| 102 | ZYME | Zymeworks Inc. | 1.93B | -2.29% | 695,585 | 134.48M |
| 103 | DNTH | Dianthus Therapeutics, Inc. | 1.87B | -0.05% | 372,397 | 3.08M |
| 104 | CLDX | Celldex Therapeutics, Inc. | 1.87B | -5.74% | 1,475,376 | 2.60M |
| 105 | SION | Sionna Therapeutics, Inc. | 1.86B | 2.14% | 178,533 | - |
| 106 | IMCR | Immunocore Holdings plc | 1.85B | -4.12% | 537,252 | 379.59M |
| 107 | MNKD | MannKind Corporation | 1.77B | 2.49% | 4,408,682 | 313.79M |
| 108 | IMNM | Immunome, Inc. | 1.75B | -2.95% | 683,576 | 9.68M |
| 109 | STOK | Stoke Therapeutics, Inc. | 1.74B | -7.67% | 1,309,825 | 205.63M |
| 110 | SNDX | Syndax Pharmaceuticals, Inc. | 1.70B | -2.35% | 1,676,678 | 111.30M |
| 111 | TRVI | Trevi Therapeutics, Inc. | 1.66B | - | 1,420,563 | - |
| 112 | ATAI | Atai Beckley N.V. | 1.59B | -1.35% | 1,916,473 | 3.02M |
| 113 | CAPR | Capricor Therapeutics, Inc. | 1.58B | -4.13% | 1,862,581 | 11.13M |
| 114 | AGIO | Agios Pharmaceuticals, Inc. | 1.57B | -1.58% | 1,002,925 | 44.79M |
| 115 | PHVS | Pharvaris N.V. | 1.56B | -5.17% | 397,017 | - |
| 116 | SVRA | Savara Inc. | 1.56B | -0.31% | 1,586,047 | - |
| 117 | INVA | Innoviva, Inc. | 1.55B | -1.38% | 936,145 | 388.52M |
| 118 | UPB | Upstream Bio, Inc. | 1.53B | -2.09% | 402,620 | 2.80M |
| 119 | ORKA | Oruka Therapeutics, Inc. | 1.49B | -2.10% | 375,492 | - |
| 120 | TSHA | Taysha Gene Therapies, Inc. | 1.45B | -2.57% | 3,664,525 | 6.31M |
| 121 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.45B | -3.15% | 1,429,778 | -665.00K |
| 122 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.41B | -4.15% | 1,429,818 | 42.34M |
| 123 | ARDX | Ardelyx, Inc. | 1.41B | -1.36% | 2,401,654 | 398.23M |
| 124 | BHVN | Biohaven Ltd. | 1.39B | -0.57% | 3,668,684 | - |
| 125 | RAPP | Rapport Therapeutics, Inc. | 1.37B | -5.01% | 423,553 | - |
| 126 | FTRE | Fortrea Holdings Inc. | 1.33B | -2.77% | 1,173,960 | 2.76B |
| 127 | KOD | Kodiak Sciences Inc. | 1.33B | -4.17% | 714,726 | - |
| 128 | RLAY | Relay Therapeutics, Inc. | 1.31B | -0.66% | 1,659,099 | 8.36M |
| 129 | QURE | uniQure N.V. | 1.29B | -4.55% | 2,111,221 | 15.75M |
| 130 | INBX | Inhibrx Biosciences, Inc. | 1.29B | -4.94% | 143,169 | 1.40M |
| 131 | MBX | MBX Biosciences, Inc. | 1.29B | -8.63% | 980,911 | - |
| 132 | PGEN | Precigen, Inc. | 1.24B | -4.88% | 2,353,579 | 6.31M |
| 133 | MNMD | Mind Medicine (MindMed) Inc. | 1.23B | -3.85% | 1,418,827 | - |
| 134 | TNGX | Tango Therapeutics, Inc. | 1.23B | -5.00% | 1,897,502 | 66.50M |
| 135 | IMTX | Immatics N.V. | 1.23B | -1.95% | 266,918 | 99.45M |
| 136 | ANAB | AnaptysBio, Inc. | 1.21B | -1.60% | 342,523 | 169.47M |
| 137 | XNCR | Xencor, Inc. | 1.20B | -4.92% | 1,684,895 | 150.13M |
| 138 | NKTR | Nektar Therapeutics | 1.20B | 2.62% | 367,421 | 62.60M |
| 139 | ALMS | Alumis Inc. | 1.19B | 2.42% | 961,581 | 22.12M |
| 140 | OCS | Oculis Holding AG | 1.19B | -0.34% | 29,402 | 992.00K |
| 141 | TYRA | Tyra Biosciences, Inc. | 1.18B | -3.16% | 489,501 | - |
| 142 | PVLA | Palvella Therapeutics, Inc. | 1.17B | -1.90% | 164,043 | - |
| 143 | PHAR | Pharming Group N.V. | 1.16B | 0.29% | 6,319 | 362.27M |
| 144 | XERS | Xeris Biopharma Holdings, Inc. | 1.16B | 0.29% | 3,290,634 | 266.14M |
| 145 | SANA | Sana Biotechnology, Inc. | 1.16B | -6.05% | 4,222,926 | - |
| 146 | ELVN | Enliven Therapeutics, Inc. | 1.16B | -5.02% | 1,417,844 | - |
| 147 | CVAC | CureVac N.V. | 1.16B | -1.44% | 1,078,524 | 83.00M |
| 148 | SEPN | Septerna, Inc. | 1.14B | -1.81% | 182,613 | 22.05M |
| 149 | GLUE | Monte Rosa Therapeutics, Inc. | 1.11B | -4.82% | 776,325 | 181.54M |
| 150 | ABCL | AbCellera Biologics Inc. | 1.10B | 2.51% | 1,927,996 | 35.33M |
| 151 | NVAX | Novavax, Inc. | 1.08B | -1.77% | 4,547,461 | 1.06B |
| 152 | NTLA | Intellia Therapeutics, Inc. | 1.08B | -1.48% | 3,135,698 | 57.53M |
| 153 | URGN | UroGen Pharma Ltd. | 1.06B | -1.65% | 534,745 | 96.52M |
| 154 | MLTX | MoonLake Immunotherapeutics | 1.04B | -3.45% | 1,654,417 | - |
| 155 | MDXG | MiMedx Group, Inc. | 1.03B | 4.49% | 753,721 | 393.44M |
| 156 | AVBP | ArriVent BioPharma, Inc. | 1.03B | -0.12% | 246,174 | - |
| 157 | NBTX | Nanobiotix S.A. | 1.03B | 1.14% | 20,409 | 11.93M |
| 158 | BCAX | Bicara Therapeutics Inc. | 1.03B | -0.90% | 554,239 | - |
| 159 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.00B | -4.64% | 204,613 | - |
| 160 | PHAT | Phathom Pharmaceuticals, Inc. | 989.70M | -4.63% | 785,154 | 147.19M |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 987.53M | -3.61% | 1,320,917 | - |
| 162 | SPRY | ARS Pharmaceuticals, Inc. | 981.57M | -0.55% | 1,911,222 | 142.77M |
| 163 | RAPT | RAPT Therapeutics, Inc. | 978.75M | 0.66% | 292,072 | - |
| 164 | JANX | Janux Therapeutics, Inc. | 946.73M | -5.07% | 1,922,466 | 10.00M |
| 165 | MRVI | Maravai LifeSciences Holdings, Inc. | 943.56M | 2.22% | 1,214,431 | 192.44M |
| 166 | ERAS | Erasca, Inc. | 936.25M | -1.20% | 1,153,154 | - |
| 167 | KURA | Kura Oncology, Inc. | 928.48M | -8.33% | 2,281,547 | 104.03M |
| 168 | VIR | Vir Biotechnology, Inc. | 926.57M | 1.22% | 1,512,427 | 16.86M |
| 169 | CRMD | CorMedix Inc. | 915.53M | 3.20% | 5,823,922 | 214.30M |
| 170 | CMPX | Compass Therapeutics, Inc. | 914.21M | -4.10% | 1,620,953 | 850.00K |
| 171 | RZLT | Rezolute, Inc. | 913.37M | -3.15% | 2,053,023 | - |
| 172 | TBPH | Theravance Biopharma, Inc. | 902.48M | -1.71% | 322,564 | 80.33M |
| 173 | IOVA | Iovance Biotherapeutics, Inc. | 893.18M | -2.60% | 7,041,799 | 250.43M |
| 174 | GHRS | GH Research PLC | 887.64M | -2.19% | 226,290 | - |
| 175 | YDES | YD Bio Limited | 884.62M | -18.42% | 364,247 | 510.36K |
| 176 | ABUS | Arbutus Biopharma Corporation | 857.77M | -1.33% | 582,134 | 14.61M |
| 177 | DAWN | Day One Biopharmaceuticals, Inc. | 847.07M | -4.51% | 2,555,644 | 133.67M |
| 178 | ARVN | Arvinas, Inc. | 841.34M | -1.65% | 918,949 | 312.30M |
| 179 | LENZ | LENZ Therapeutics, Inc. | 827.62M | -0.97% | 683,315 | 17.50M |
| 180 | MPLT | MapLight Therapeutics, Inc. | 822.64M | 2.17% | 188,004 | - |
| 181 | KALV | KalVista Pharmaceuticals, Inc. | 816.83M | -4.15% | 1,035,353 | 1.43M |
| 182 | OMER | Omeros Corporation | 813.23M | 0.61% | 1,100,968 | - |
| 183 | IVA | Inventiva S.A. | 809.31M | -0.23% | 80,940 | 19.93M |
| 184 | REPL | Replimune Group, Inc. | 807.97M | -4.01% | 1,564,503 | - |
| 185 | GOSS | Gossamer Bio, Inc. | 798.52M | 1.17% | 1,646,516 | 44.05M |
| 186 | FULC | Fulcrum Therapeutics, Inc. | 790.13M | 12.39% | 3,878,859 | 80.00M |
| 187 | GERN | Geron Corporation | 785.18M | -3.15% | 4,298,725 | 183.40M |
| 188 | VSTM | Verastem, Inc. | 781.08M | -1.27% | 2,047,836 | 13.38M |
| 189 | RIGL | Rigel Pharmaceuticals, Inc. | 768.35M | -2.47% | 455,402 | 282.08M |
| 190 | VALN | Valneva SE | 756.72M | -3.36% | 15,166 | 211.09M |
| 191 | PRME | Prime Medicine, Inc. | 741.79M | -0.48% | 2,982,833 | 5.98M |
| 192 | ATXS | Astria Therapeutics, Inc. | 739.25M | -0.38% | 1,142,197 | 706.00K |
| 193 | GYRE | Gyre Therapeutics, Inc. | 730.76M | -1.47% | 56,563 | 107.27M |
| 194 | CGEM | Cullinan Therapeutics, Inc. | 730.18M | -0.64% | 1,288,096 | - |
| 195 | ANNX | Annexon, Inc. | 724.41M | - | 2,243,894 | - |
| 196 | LXEO | Lexeo Therapeutics, Inc. | 694.11M | 0.63% | 735,532 | - |
| 197 | MGTX | MeiraGTx Holdings plc | 679.34M | -2.54% | 293,049 | 27.42M |
| 198 | PROK | ProKidney Corp. | 664.84M | -5.96% | 1,178,779 | 744.00K |
| 199 | CTMX | CytomX Therapeutics, Inc. | 659.10M | 0.52% | 1,005,919 | 113.63M |
| 200 | CRVS | Corvus Pharmaceuticals, Inc. | 647.49M | 1.29% | 1,718,417 | - |
| 201 | RGNX | REGENXBIO Inc. | 643.93M | -3.93% | 543,850 | 161.32M |
| 202 | LYEL | Lyell Immunopharma, Inc. | 621.06M | 3.21% | 115,425 | 41.00K |
| 203 | JBIO | Jade Biosciences, Inc. | 621.06M | 0.15% | 150,567 | - |
| 204 | DBVT | DBV Technologies S.A. | 616.88M | 1.06% | 257,854 | 5.50M |
| 205 | DRUG | Bright Minds Biosciences Inc. | 609.37M | -4.59% | 68,759 | - |
| 206 | VTYX | Ventyx Biosciences, Inc. | 607.26M | -3.30% | 1,226,186 | - |
| 207 | FDMT | 4D Molecular Therapeutics, Inc. | 600.49M | -5.14% | 816,003 | 120.00K |
| 208 | IVVD | Invivyd, Inc. | 578.14M | 4.20% | 4,280,356 | 50.04M |
| 209 | ALT | Altimmune, Inc. | 575.97M | -1.60% | 4,808,850 | 20.00K |
| 210 | ASMB | Assembly Biosciences, Inc. | 564.20M | 0.82% | 162,372 | 37.19M |
| 211 | LBRX | LB Pharmaceuticals Inc | 556.07M | -2.31% | 339,461 | - |
| 212 | PRTA | Prothena Corporation plc | 555.53M | -3.82% | 532,153 | 11.79M |
| 213 | ENGN | enGene Holdings Inc. | 550.36M | -1.56% | 749,198 | - |
| 214 | DNA | Ginkgo Bioworks Holdings, Inc. | 543.35M | 1.70% | 952,054 | 180.61M |
| 215 | EVMN | Evommune, Inc. | 536.58M | -3.25% | 159,616 | 3.00M |
| 216 | ABSI | Absci Corporation | 529.31M | 2.03% | 2,575,335 | 2.82M |
| 217 | DSGN | Design Therapeutics, Inc. | 528.05M | -5.98% | 221,595 | - |
| 218 | NAGE | Niagen Bioscience, Inc. | 521.38M | 0.31% | 925,349 | 124.71M |
| 219 | MNPR | Monopar Therapeutics Inc. | 504.13M | -1.30% | 211,655 | - |
| 220 | BCYC | Bicycle Therapeutics plc | 491.82M | -4.19% | 201,914 | 28.34M |
| 221 | ZVRA | Zevra Therapeutics, Inc. | 483.03M | -2.28% | 927,390 | 84.39M |
| 222 | LXRX | Lexicon Pharmaceuticals, Inc. | 476.05M | -5.76% | 2,012,244 | 70.86M |
| 223 | DMAC | DiaMedica Therapeutics Inc. | 472.34M | 3.54% | 578,519 | - |
| 224 | NBP | NovaBridge Biosciences | 463.37M | - | 298,796 | - |
| 225 | BNTC | Benitec Biopharma Inc. | 451.04M | 0.99% | 143,499 | - |
| 226 | SLDB | Solid Biosciences Inc. | 447.98M | 0.70% | 1,238,282 | - |
| 227 | ADCT | ADC Therapeutics SA | 437.29M | 9.63% | 1,537,824 | 75.21M |
| 228 | ENTA | Enanta Pharmaceuticals, Inc. | 422.55M | 3.24% | 251,402 | 65.32M |
| 229 | LCTX | Lineage Cell Therapeutics, Inc. | 421.65M | 2.96% | 1,374,309 | 10.82M |
| 230 | KROS | Keros Therapeutics, Inc. | 420.18M | 0.98% | 474,377 | 246.72M |
| 231 | ANRO | Alto Neuroscience, Inc. | 411.63M | -4.26% | 332,076 | - |
| 232 | PRTC | PureTech Health plc | 404.15M | 0.97% | 2,420 | 6.39M |
| 233 | AURA | Aura Biosciences, Inc. | 403.25M | -0.78% | 98,915 | - |
| 234 | IMRX | Immuneering Corporation | 402.92M | -4.29% | 663,012 | - |
| 235 | VTVT | vTv Therapeutics Inc. | 400.31M | 5.74% | 6,436 | 17.00K |
| 236 | TENX | Tenax Therapeutics, Inc. | 399.62M | -4.37% | 195,917 | - |
| 237 | XOMA | XOMA Royalty Corporation | 397.25M | 5.21% | 83,043 | 47.11M |
| 238 | AUTL | Autolus Therapeutics plc | 396.55M | -6.29% | 2,058,791 | 51.13M |
| 239 | AVXL | Anavex Life Sciences Corp. | 394.03M | 1.61% | 1,149,974 | - |
| 240 | PEPG | PepGen Inc. | 391.86M | 1.97% | 629,567 | - |
| 241 | GALT | Galectin Therapeutics Inc. | 382.97M | -1.33% | 527,490 | - |
| 242 | TRDA | Entrada Therapeutics, Inc. | 379.77M | -4.08% | 119,873 | 61.52M |
| 243 | OCGN | Ocugen, Inc. | 377.91M | 0.83% | 2,597,301 | 5.37M |
| 244 | TECX | Tectonic Therapeutic, Inc. | 368.15M | -1.70% | 155,113 | - |
| 245 | CTNM | Contineum Therapeutics, Inc. | 364.78M | 2.04% | 321,397 | - |
| 246 | RCKT | Rocket Pharmaceuticals, Inc. | 363.63M | -4.00% | 1,304,200 | - |
| 247 | DRTS | Alpha Tau Medical Ltd. | 360.67M | 8.74% | 1,925,683 | - |
| 248 | FBRX | Forte Biosciences, Inc. | 358.23M | 1.77% | 106,583 | - |
| 249 | VNDA | Vanda Pharmaceuticals Inc. | 358.13M | -1.30% | 1,649,828 | 212.07M |
| 250 | NMRA | Neumora Therapeutics, Inc. | 352.62M | -5.25% | 744,802 | - |
| 251 | AVTX | Avalo Therapeutics, Inc. | 348.90M | -1.03% | 319,157 | 192.00K |
| 252 | ACRS | Aclaris Therapeutics, Inc. | 347.79M | -2.13% | 1,384,057 | 15.74M |
| 253 | MREO | Mereo BioPharma Group plc | 346.91M | 2.35% | 2,550,675 | 500.00K |
| 254 | KYTX | Kyverna Therapeutics, Inc. | 346.43M | -4.35% | 393,475 | - |
| 255 | LRMR | Larimar Therapeutics, Inc. | 344.93M | 5.50% | 1,098,665 | - |
| 256 | CLLS | Cellectis S.A. | 337.97M | -1.19% | 87,844 | 82.55M |
| 257 | ALLO | Allogene Therapeutics, Inc. | 319.12M | -2.07% | 3,815,888 | 22.00K |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 318.27M | -5.21% | 1,239,319 | 33.98M |
| 259 | GUTS | Fractyl Health, Inc. | 313.83M | 2.69% | 4,531,136 | 3.00K |
| 260 | IMMP | Immutep Limited | 313.72M | -0.88% | 1,229,784 | 3.31M |
| 261 | CADL | Candel Therapeutics, Inc. | 310.72M | 3.85% | 795,823 | - |
| 262 | NGNE | Neurogene Inc. | 305.77M | -4.13% | 139,071 | 925.00K |
| 263 | RLMD | Relmada Therapeutics, Inc. | 303.60M | -0.72% | 1,228,427 | - |
| 264 | EPRX | Eupraxia Pharmaceuticals Inc. | 303.18M | -0.50% | 21,803 | - |
| 265 | AARD | Aardvark Therapeutics, Inc. | 298.08M | -0.94% | 255,166 | - |
| 266 | TARA | Protara Therapeutics, Inc. | 296.36M | 0.35% | 868,835 | - |
| 267 | SLN | Silence Therapeutics plc | 292.85M | -10.27% | 224,791 | 25.83M |
| 268 | ALDX | Aldeyra Therapeutics, Inc. | 288.18M | -3.23% | 1,705,954 | - |
| 269 | CYBN | Cybin Inc. | 286.95M | -2.71% | 434,089 | - |
| 270 | OABI | OmniAb, Inc. | 286.47M | - | 614,721 | 21.09M |
| 271 | ABEO | Abeona Therapeutics Inc. | 283.96M | 2.14% | 1,442,176 | 400.00K |
| 272 | PALI | Palisade Bio, Inc. | 283.11M | 4.97% | 4,509,114 | - |
| 273 | PBYI | Puma Biotechnology, Inc. | 278.16M | 2.22% | 480,400 | 212.00M |
| 274 | CBIO | Crescent Biopharma, Inc. | 273.11M | 6.07% | 313,241 | - |
| 275 | SLS | SELLAS Life Sciences Group, Inc. | 270.64M | 4.40% | 5,987,206 | - |
| 276 | PYXS | Pyxis Oncology, Inc. | 267.74M | 2.87% | 289,834 | 2.82M |
| 277 | MIST | Milestone Pharmaceuticals Inc. | 267.16M | -1.13% | 4,313,886 | - |
| 278 | FENC | Fennec Pharmaceuticals Inc. | 260.59M | 1.19% | 87,840 | 38.79M |
| 279 | NAUT | Nautilus Biotechnology, Inc. | 257.66M | 0.49% | 259,023 | - |
| 280 | ACIU | AC Immune SA | 251.32M | -8.63% | 424,790 | 5.48M |
| 281 | CCCC | C4 Therapeutics, Inc. | 251.01M | 1.97% | 980,580 | 30.11M |
| 282 | ACHV | Achieve Life Sciences, Inc. | 249.14M | -0.21% | 394,597 | - |
| 283 | FHTX | Foghorn Therapeutics Inc. | 246.56M | -2.02% | 97,117 | 24.52M |
| 284 | AVIR | Atea Pharmaceuticals, Inc. | 245.32M | -1.88% | 325,694 | - |
| 285 | ZURA | Zura Bio Limited | 244.49M | -0.27% | 222,400 | - |
| 286 | PRQR | ProQR Therapeutics N.V. | 244.40M | 9.43% | 863,516 | 18.86M |
| 287 | HRTX | Heron Therapeutics, Inc. | 243.87M | -1.48% | 1,622,750 | 155.10M |
| 288 | CABA | Cabaletta Bio, Inc. | 240.66M | 0.81% | 1,761,354 | - |
| 289 | VYGR | Voyager Therapeutics, Inc. | 238.52M | -0.69% | 288,093 | 31.32M |
| 290 | EDIT | Editas Medicine, Inc. | 238.19M | 0.83% | 1,189,591 | 46.38M |
| 291 | HUMA | Humacyte, Inc. | 237.83M | -1.55% | 4,447,760 | 1.57M |
| 292 | OBIO | Orchestra BioMed Holdings, Inc. | 237.15M | -4.33% | 241,157 | 2.82M |
| 293 | MDWD | MediWound Ltd. | 236.81M | -0.22% | 65,379 | 20.93M |
| 294 | TNYA | Tenaya Therapeutics, Inc. | 234.77M | 1.44% | 1,302,494 | - |
| 295 | TNXP | Tonix Pharmaceuticals Holding Corp. | 230.82M | -1.46% | 573,385 | 10.30M |
| 296 | NBY | NovaBay Pharmaceuticals, Inc. | 228.08M | 16.77% | 821,980 | 10.30M |
| 297 | ETHZ | ETHZilla Corporation | 224.09M | 5.05% | 804,721 | 4.11M |
| 298 | ARMP | Armata Pharmaceuticals, Inc. | 223.07M | 11.64% | 47,105 | 5.05M |
| 299 | IMMX | Immix Biopharma, Inc. | 221.61M | 7.32% | 2,907,535 | - |
| 300 | VOR | Vor Biopharma Inc. | 218.80M | 28.23% | 41,894,805 | - |
| 301 | CAMP | Camp4 Therapeutics Corporation | 215.65M | 26.03% | 212,558 | 3.80M |
| 302 | QNCX | Quince Therapeutics, Inc. | 214.93M | -1.03% | 425,332 | - |
| 303 | TLSA | Tiziana Life Sciences Ltd | 205.57M | 3.59% | 341,893 | - |
| 304 | RNAC | Cartesian Therapeutics, Inc. | 205.43M | 17.56% | 807,498 | 1.09M |
| 305 | ARCT | Arcturus Therapeutics Holdings Inc. | 204.57M | -3.36% | 668,570 | 97.60M |
| 306 | SGMT | Sagimet Biosciences Inc. | 204.24M | 1.45% | 382,057 | - |
| 307 | STTK | Shattuck Labs, Inc. | 198.70M | 4.32% | 431,882 | 1.00M |
| 308 | SRZN | Surrozen, Inc. | 189.43M | 7.96% | 175,652 | 3.60M |
| 309 | RANI | Rani Therapeutics Holdings, Inc. | 188.36M | -0.64% | 1,837,731 | 1.20M |
| 310 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 187.14M | -2.60% | 314,110 | - |
| 311 | VTGN | Vistagen Therapeutics, Inc. | 179.70M | 6.06% | 766,629 | 721.00K |
| 312 | SABS | SAB Biotherapeutics, Inc. | 179.00M | 5.92% | 355,112 | 114.70K |
| 313 | NVCT | Nuvectis Pharma, Inc. | 178.54M | 4.81% | 184,834 | - |
| 314 | IPHA | Innate Pharma S.A. | 176.35M | -0.37% | 12,202 | 14.84M |
| 315 | CRBU | Caribou Biosciences, Inc. | 174.79M | -1.06% | 718,743 | 9.30M |
| 316 | ACTU | Actuate Therapeutics, Inc. | 173.16M | -0.53% | 57,037 | - |
| 317 | NTHI | NeOnc Technologies Holdings, Inc. | 171.76M | -2.97% | 50,430 | 59.99K |
| 318 | GNLX | Genelux Corporation | 171.16M | 4.12% | 130,530 | 8.00K |
| 319 | IKT | Inhibikase Therapeutics, Inc. | 170.99M | 1.39% | 242,841 | 1.00 |
| 320 | SGMO | Sangamo Therapeutics, Inc. | 169.36M | -0.16% | 3,091,494 | 32.88M |
| 321 | CDXS | Codexis, Inc. | 168.45M | -2.86% | 601,151 | 52.93M |
| 322 | ANIX | Anixa Biosciences, Inc. | 166.56M | -3.07% | 465,146 | - |
| 323 | IRD | Opus Genetics, Inc. | 164.82M | 4.37% | 4,646,841 | 14.63M |
| 324 | CRDF | Cardiff Oncology, Inc. | 162.34M | 2.99% | 1,920,592 | 501.00K |
| 325 | SAVA | Cassava Sciences, Inc. | 156.52M | 1.25% | 663,137 | - |
| 326 | CHRS | Coherus Oncology, Inc. | 155.92M | 0.78% | 1,084,611 | 277.73M |
| 327 | BDTX | Black Diamond Therapeutics, Inc. | 154.40M | -1.45% | 1,014,089 | 70.00M |
| 328 | CGEN | Compugen Ltd. | 154.33M | 6.45% | 759,188 | 6.90M |
| 329 | MOLN | Molecular Partners AG | 151.95M | 2.42% | 1,825 | 856.30K |
| 330 | MCRB | Seres Therapeutics, Inc. | 151.80M | -2.33% | 95,758 | 351.00K |
| 331 | INO | Inovio Pharmaceuticals, Inc. | 149.77M | 4.31% | 1,682,210 | 182.34K |
| 332 | CGTX | Cognition Therapeutics, Inc. | 148.30M | -4.00% | 716,105 | - |
| 333 | GANX | Gain Therapeutics, Inc. | 146.78M | 1.50% | 1,430,390 | - |
| 334 | ELTX | Elicio Therapeutics, Inc. | 140.85M | -4.50% | 166,379 | - |
| 335 | PLX | Protalix BioTherapeutics, Inc. | 140.74M | 0.57% | 377,115 | 61.84M |
| 336 | MRSN | Mersana Therapeutics, Inc. | 140.66M | 0.79% | 45,629 | 33.18M |
| 337 | UNCY | Unicycive Therapeutics, Inc. | 140.12M | -0.91% | 370,800 | - |
| 338 | PRLD | Prelude Therapeutics Incorporated | 140.08M | 16.44% | 629,229 | 10.50M |
| 339 | ALEC | Alector, Inc. | 139.71M | 4.92% | 2,351,001 | 69.05M |
| 340 | GLSI | Greenwich LifeSciences, Inc. | 137.02M | 2.91% | 96,680 | - |
| 341 | NKTX | Nkarta, Inc. | 134.96M | 3.83% | 712,577 | - |
| 342 | AGEN | Agenus Inc. | 133.31M | -2.73% | 478,939 | 106.83M |
| 343 | KLRS | Kalaris Therapeutics, Inc. | 133.16M | 15.58% | 299,503 | - |
| 344 | CNTB | Connect Biopharma Holdings Limited | 133.05M | -1.24% | 88,990 | 762.00K |
| 345 | VRCA | Verrica Pharmaceuticals Inc. | 132.24M | 1.97% | 182,563 | 30.83M |
| 346 | SPRO | Spero Therapeutics, Inc. | 131.27M | 0.87% | 348,849 | 40.55M |
| 347 | ACOG | Alpha Cognition Inc. | 130.24M | -0.33% | 66,547 | 7.43M |
| 348 | CLYM | Climb Bio, Inc. | 129.55M | 4.97% | 576,707 | - |
| 349 | COYA | Coya Therapeutics, Inc. | 128.48M | 1.15% | 190,684 | 3.99M |
| 350 | FATE | Fate Therapeutics, Inc. | 121.12M | -1.87% | 924,436 | 7.14M |
| 351 | WHWK | Whitehawk Therapeutics, Inc. | 121.12M | 7.53% | 181,637 | 14.38M |
| 352 | ANVS | Annovis Bio, Inc. | 118.20M | 3.72% | 716,205 | - |
| 353 | ABOS | Acumen Pharmaceuticals, Inc. | 118.12M | 0.52% | 106,309 | - |
| 354 | EXOZ | eXoZymes, Inc. | 117.51M | -0.78% | 1,769 | -700.00 |
| 355 | ELDN | Eledon Pharmaceuticals, Inc. | 117.23M | -1.89% | 663,680 | - |
| 356 | DTIL | Precision BioSciences, Inc. | 116.99M | 2.10% | 234,962 | 698.00K |
| 357 | ATRA | Atara Biotherapeutics, Inc. | 113.13M | 4.05% | 62,315 | 151.93M |
| 358 | OVID | Ovid Therapeutics Inc. | 111.80M | -0.63% | 1,601,654 | 6.61M |
| 359 | SLGL | Sol-Gel Technologies Ltd. | 111.78M | -4.44% | 10,191 | 18.97M |
| 360 | VANI | Vivani Medical, Inc. | 110.89M | 4.83% | 220,967 | - |
| 361 | CNTX | Context Therapeutics Inc. | 110.85M | -1.89% | 502,544 | - |
| 362 | KPTI | Karyopharm Therapeutics Inc. | 108.96M | 8.49% | 360,892 | 142.53M |
| 363 | ORMP | Oramed Pharmaceuticals Inc. | 106.67M | -0.37% | 40,657 | 2.00M |
| 364 | ATOS | Atossa Therapeutics, Inc. | 104.46M | 3.47% | 580,556 | - |
| 365 | ONCY | Oncolytics Biotech Inc. | 103.68M | 3.40% | 399,271 | - |
| 366 | SEER | Seer, Inc. | 102.65M | -0.54% | 106,192 | 16.38M |
| 367 | SPRB | Spruce Biosciences, Inc. | 101.85M | 16.49% | 143,965 | 697.00K |
| 368 | ZNTL | Zentalis Pharmaceuticals, Inc. | 99.71M | -2.13% | 332,171 | 26.87M |
| 369 | TTRX | Turn Therapeutics Inc. | 98.94M | -0.30% | 34,404 | - |
| 370 | ENTX | Entera Bio Ltd. | 96.30M | -1.41% | 59,112 | 124.00K |
| 371 | ADVM | Adverum Biotechnologies, Inc. | 96.26M | - | - | 1.00M |
| 372 | BMEA | Biomea Fusion, Inc. | 94.74M | -0.74% | 1,436,466 | - |
| 373 | ANEB | Anebulo Pharmaceuticals, Inc. | 94.49M | 1.32% | 8,506 | - |
| 374 | RPTX | Repare Therapeutics Inc. | 92.85M | 0.47% | 429,483 | 11.87M |
| 375 | OTLK | Outlook Therapeutics, Inc. | 92.39M | 4.00% | 2,072,190 | 1.51M |
| 376 | PSTV | Plus Therapeutics, Inc. | 92.08M | 6.35% | 6,184,412 | 5.26M |
| 377 | CBUS | Cibus, Inc. | 91.74M | 6.29% | 272,961 | 3.79M |
| 378 | THAR | Tharimmune, Inc. | 91.12M | 3.17% | 291,035 | - |
| 379 | ADAG | Adagene Inc. | 90.21M | -3.82% | 13,209 | 103.20K |
| 380 | TVGN | Tevogen Bio Holdings Inc. | 89.61M | 3.46% | 18,325,654 | - |
| 381 | HYFT | MindWalk Holdings Corp. | 89.54M | 0.52% | 195,662 | 18.21M |
| 382 | FBIO | Fortress Biotech, Inc. | 88.15M | -1.73% | 198,072 | 62.30M |
| 383 | MGNX | MacroGenics, Inc. | 87.93M | 4.51% | 1,160,021 | 127.63M |
| 384 | VXRT | Vaxart, Inc. | 87.44M | -0.27% | - | 148.20M |
| 385 | ACET | Adicet Bio, Inc. | 86.70M | 2.29% | 2,616,157 | - |
| 386 | CSBR | Champions Oncology, Inc. | 86.45M | 0.16% | 8,205 | 56.88M |
| 387 | COEP | Coeptis Therapeutics Holdings, Inc. | 83.36M | 1.36% | 88,999 | 501.00K |
| 388 | IMUX | Immunic, Inc. | 80.64M | 0.13% | 1,056,531 | - |
| 389 | ESLA | Estrella Immunopharma, Inc. | 80.06M | 3.41% | 106,245 | - |
| 390 | CRVO | CervoMed Inc. | 79.85M | -1.82% | 21,343 | 6.16M |
| 391 | BYSI | BeyondSpring Inc. | 79.78M | -2.02% | 26,432 | 1.88M |
| 392 | ALXO | ALX Oncology Holdings Inc. | 79.70M | 1.39% | 166,508 | - |
| 393 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 79.66M | 10.82% | 9,490,204 | - |
| 394 | ATYR | aTyr Pharma, Inc. | 79.20M | -0.48% | 1,081,359 | 190.00K |
| 395 | ACRV | Acrivon Therapeutics, Inc. | 78.57M | -1.19% | 699,849 | - |
| 396 | PTHS | Pelthos Therapeutics Inc. | 78.15M | -6.67% | 11,235 | 7.41M |
| 397 | PLRX | Pliant Therapeutics, Inc. | 77.43M | -1.56% | 1,185,738 | - |
| 398 | ARTV | Artiva Biotherapeutics, Inc. | 76.58M | 1.30% | 135,501 | 251.00K |
| 399 | MNOV | MediciNova, Inc. | 75.53M | 1.99% | 72,617 | 257.92K |
| 400 | TIL | Instil Bio, Inc. | 74.87M | -0.63% | 33,939 | - |
| 401 | OKYO | OKYO Pharma Limited | 74.09M | 3.14% | 47,682 | - |
| 402 | XBIT | XBiotech Inc. | 73.17M | -1.64% | 60,125 | - |
| 403 | STRO | Sutro Biopharma, Inc. | 72.28M | -0.12% | 120,538 | 105.65M |
| 404 | IFRX | InflaRx N.V. | 71.81M | - | 604,230 | 73.73K |
| 405 | IMA | ImageneBio, Inc. | 70.40M | 1.07% | 168,287 | 800.00K |
| 406 | OSTX | OS Therapies Incorporated | 69.02M | - | 519,820 | - |
| 407 | KRRO | Korro Bio, Inc. | 68.28M | -3.85% | 282,736 | 7.37M |
| 408 | ALGS | Aligos Therapeutics, Inc. | 68.18M | 2.78% | 44,745 | 2.65M |
| 409 | LITS | Lite Strategy, Inc. | 67.32M | 6.40% | 462,206 | - |
| 410 | MGX | Metagenomi, Inc. | 67.21M | -1.10% | 222,005 | 30.91M |
| 411 | CALC | CalciMedica, Inc. | 66.72M | 4.99% | 67,767 | - |
| 412 | PYPD | PolyPid Ltd. | 66.21M | - | 91,718 | - |
| 413 | NRXP | NRx Pharmaceuticals, Inc. | 66.03M | 3.98% | 349,493 | 242.00K |
| 414 | PMVP | PMV Pharmaceuticals, Inc. | 65.98M | 5.98% | 353,060 | - |
| 415 | ATHE | Alterity Therapeutics Limited | 65.11M | 2.13% | 18,986 | 3.57M |
| 416 | INKT | MiNK Therapeutics, Inc. | 60.98M | 8.16% | 45,274 | - |
| 417 | IOBT | IO Biotech, Inc. | 60.91M | 12.62% | 1,344,198 | - |
| 418 | HURA | TuHURA Biosciences, Inc. | 59.97M | -40.91% | 3,299,201 | - |
| 419 | NTRB | Nutriband Inc. | 59.24M | -0.20% | 18,342 | 2.58M |
| 420 | PDSB | PDS Biotechnology Corporation | 58.00M | 18.00% | 2,300,029 | - |
| 421 | INMB | INmune Bio, Inc. | 57.69M | 6.37% | 1,142,672 | 50.00K |
| 422 | TCRX | TScan Therapeutics, Inc. | 57.60M | 1.50% | 623,351 | 8.42M |
| 423 | IBO | Impact BioMedical Inc. | 55.99M | 6.47% | 124,106 | 25.00K |
| 424 | EVAX | Evaxion A/S | 55.05M | 5.57% | 312,522 | 7.65M |
| 425 | EQ | Equillium, Inc. | 54.80M | 2.93% | 453,832 | 4.39M |
| 426 | CVM | CEL-SCI Corporation | 53.39M | 6.22% | 42,697 | - |
| 427 | ABVC | ABVC BioPharma, Inc. | 52.56M | 5.19% | 92,162 | 797.92K |
| 428 | IPSC | Century Therapeutics, Inc. | 51.66M | 3.81% | 669,896 | 113.34M |
| 429 | CELU | Celularity Inc. | 51.28M | -4.23% | 60,866 | 40.58M |
| 430 | ICCC | ImmuCell Corporation | 50.39M | 1.64% | 6,401 | 27.77M |
| 431 | MAIA | MAIA Biotechnology, Inc. | 49.99M | 9.76% | 1,580,705 | - |
| 432 | IBIO | iBio, Inc. | 49.92M | 32.93% | 48,021,643 | 500.00K |
| 433 | JSPR | Jasper Therapeutics, Inc. | 49.53M | 2.91% | 649,853 | - |
| 434 | TELO | Telomir Pharmaceuticals, Inc. | 49.16M | 1.42% | 148,708 | - |
| 435 | GRCE | Grace Therapeutics, Inc. | 49.03M | 3.58% | 129,765 | - |
| 436 | HOWL | Werewolf Therapeutics, Inc. | 49.03M | 1.00% | 284,250 | 1.14M |
| 437 | BCAB | BioAtla, Inc. | 47.35M | -0.58% | 657,445 | 11.00M |
| 438 | BTAI | BioXcel Therapeutics, Inc. | 46.58M | -3.18% | 437,399 | 752.00K |
| 439 | XCUR | Exicure, Inc. | 46.47M | 36.77% | 30,426,878 | 500.00K |
| 440 | KZR | Kezar Life Sciences, Inc. | 45.92M | -0.16% | 33,561 | - |
| 441 | OKUR | OnKure Therapeutics, Inc. | 45.12M | -2.63% | 157,993 | - |
| 442 | ATNM | Actinium Pharmaceuticals, Inc. | 44.61M | 2.14% | 259,139 | 90.00K |
| 443 | LTRN | Lantern Pharma Inc. | 43.40M | 0.78% | 53,441 | - |
| 444 | VERU | Veru Inc. | 42.21M | -0.75% | 119,036 | 16.89M |
| 445 | GNTA | Genenta Science S.p.A. | 41.71M | -1.66% | 102,614 | - |
| 446 | ANL | Adlai Nortye Ltd. | 40.59M | 25.00% | 110,617 | 1.94M |
| 447 | SNTI | Senti Biosciences, Inc. | 40.49M | -35.56% | 73,591,178 | - |
| 448 | TVRD | Tvardi Therapeutics, Inc. | 40.25M | 2.63% | 95,669 | - |
| 449 | QTTB | Q32 Bio Inc. | 39.87M | -6.36% | 360,163 | - |
| 450 | CUE | Cue Biopharma, Inc. | 38.94M | -6.38% | 667,217 | 7.10M |
| 451 | JUNS | Jupiter Neurosciences, Inc. | 38.90M | -0.88% | 39,600 | - |
| 452 | SKYE | Skye Bioscience, Inc. | 38.79M | - | 250,452 | - |
| 453 | APLM | Apollomics, Inc. | 38.63M | 7.72% | 29,680 | 198.00K |
| 454 | QNTM | Quantum BioPharma Ltd. | 38.59M | 4.94% | 51,973 | - |
| 455 | XLO | Xilio Therapeutics, Inc. | 38.44M | 0.30% | 474,603 | 31.80M |
| 456 | RNTX | Rein Therapeutics Inc. | 38.12M | 4.32% | 240,309 | - |
| 457 | NXTC | NextCure, Inc. | 37.75M | -1.42% | 34,064 | - |
| 458 | GLTO | Galecto, Inc. | 36.88M | 8.01% | 169,412 | - |
| 459 | GBIO | Generation Bio Co. | 36.25M | 1.70% | 31,595 | 15.27M |
| 460 | DYAI | Dyadic International, Inc. | 36.19M | 1.01% | 105,577 | 3.34M |
| 461 | APLT | Applied Therapeutics, Inc. | 36.15M | 13.86% | 9,263,264 | 1.00M |
| 462 | RADX | Radiopharm Theranostics Limited | 35.31M | -3.69% | 43,481 | 8.20M |
| 463 | SER | Serina Therapeutics, Inc. | 35.30M | -0.30% | 12,654 | 116.00K |
| 464 | RNXT | RenovoRx, Inc. | 35.18M | 1.90% | 201,650 | 928.00K |
| 465 | FGEN | FibroGen, Inc. | 34.10M | 0.84% | 18,339 | 8.30M |
| 466 | PASG | Passage Bio, Inc. | 33.06M | 4.84% | 40,774 | - |
| 467 | KLTO | Klotho Neurosciences, Inc. | 32.64M | -0.11% | 690,871 | - |
| 468 | PLUR | Pluri Inc. | 31.83M | 9.90% | 115,853 | 1.33M |
| 469 | INTS | Intensity Therapeutics, Inc. | 31.67M | 5.14% | 2,012,732 | - |
| 470 | ANTX | AN2 Therapeutics, Inc. | 31.51M | 4.55% | 72,111 | - |
| 471 | RLYB | Rallybio Corporation | 30.53M | 6.37% | 345,624 | 674.00K |
| 472 | LNAI | Lunai Bioworks Inc. | 29.52M | -8.70% | 1,352,777 | - |
| 473 | NRXS | NeurAxis, Inc. | 28.76M | 2.66% | 21,650 | 3.36M |
| 474 | KZIA | Kazia Therapeutics Limited | 28.56M | -0.95% | 184,208 | 1.20M |
| 475 | BRNS | Barinthus Biotherapeutics plc | 27.68M | -3.54% | 37,623 | 14.97M |
| 476 | IGC | IGC Pharma, Inc. | 27.67M | 2.48% | 303,828 | 1.11M |
| 477 | NERV | Minerva Neurosciences, Inc. | 27.27M | 0.78% | 42,306 | - |
| 478 | HYPD | Hyperion DeFi, Inc. | 26.93M | 1.08% | 319,200 | 345.32K |
| 479 | DARE | Daré Bioscience, Inc. | 26.58M | 1.09% | 54,809 | -57.13K |
| 480 | CING | Cingulate Inc. | 26.42M | -0.26% | 115,068 | - |
| 481 | BOLD | Boundless Bio, Inc. | 26.41M | 3.51% | 130,231 | - |
| 482 | KTTA | Pasithea Therapeutics Corp. | 26.21M | 3.54% | 597,689 | - |
| 483 | LEXX | Lexaria Bioscience Corp. | 25.12M | 3.67% | 167,564 | 705.92K |
| 484 | MRKR | Marker Therapeutics, Inc. | 24.84M | 4.93% | 313,084 | 4.69M |
| 485 | ENLV | Enlivex Therapeutics Ltd. | 24.78M | -7.27% | 1,108,934 | - |
| 486 | NEUP | Neuphoria Therapeutics Inc. | 24.74M | 1.32% | 73,950 | 15.65M |
| 487 | NNVC | NanoViricides, Inc. | 24.66M | -4.20% | 475,702 | - |
| 488 | LIXT | Lixte Biotechnology Holdings, Inc. | 24.01M | -3.00% | 96,956 | - |
| 489 | ITRM | Iterum Therapeutics plc | 23.91M | 1.07% | 352,876 | 390.00K |
| 490 | NRSN | NeuroSense Therapeutics Ltd. | 23.79M | -4.04% | 437,156 | - |
| 491 | LIMN | Liminatus Pharma, Inc. | 23.70M | 1.37% | 118,263 | - |
| 492 | BCTX | BriaCell Therapeutics Corp. | 22.92M | -2.15% | 65,651 | - |
| 493 | CLGN | CollPlant Biotechnologies Ltd. | 22.61M | -13.24% | 70,528 | 2.48M |
| 494 | PTN | Palatin Technologies, Inc. | 22.39M | 28.62% | 62,812 | 8.85M |
| 495 | CTXR | Citius Pharmaceuticals, Inc. | 22.17M | 7.14% | 428,988 | - |
| 496 | PLRZ | Polyrizon Ltd. | 21.16M | -2.99% | 409,705 | - |
| 497 | APVO | Aptevo Therapeutics Inc. | 20.89M | -7.46% | 2,030,760 | - |
| 498 | NCEL | NewcelX Ltd. | 20.74M | 17.57% | 289,948 | - |
| 499 | CVKD | Cadrenal Therapeutics, Inc. | 20.70M | 0.40% | 28,059 | - |
| 500 | TRAW | Traws Pharma, Inc. | 19.42M | 12.50% | 144,545 | 2.85M |
| 501 | MTVA | MetaVia Inc. | 19.02M | -25.00% | 239,537 | - |
| 502 | HOTH | Hoth Therapeutics, Inc. | 18.46M | 2.59% | 85,886 | - |
| 503 | LPCN | Lipocine Inc. | 18.15M | - | 6,445 | 4.32M |
| 504 | ALLR | Allarity Therapeutics, Inc. | 18.03M | -1.72% | 251,719 | - |
| 505 | FBLG | FibroBiologics, Inc. | 18.02M | 6.21% | 1,253,078 | - |
| 506 | KAPA | Kairos Pharma, Ltd. | 17.89M | -1.14% | 75,935 | - |
| 507 | GDTC | CytoMed Therapeutics Limited | 17.89M | -16.22% | 100,249 | 573.19K |
| 508 | LSTA | Lisata Therapeutics, Inc. | 17.86M | 3.85% | 12,471 | 1.07M |
| 509 | NCNA | NuCana plc | 17.81M | 3.38% | 34,113 | - |
| 510 | CASI | CASI Pharmaceuticals, Inc. | 17.61M | -7.86% | 72,430 | 26.85M |
| 511 | OSRH | OSR Holdings, Inc. | 17.53M | -5.42% | 510,845 | -90.52K |
| 512 | PMN | ProMIS Neurosciences, Inc. | 17.49M | 6.63% | 12,023 | - |
| 513 | PCSA | Processa Pharmaceuticals, Inc. | 17.27M | 7.36% | 785,513 | - |
| 514 | CRIS | Curis, Inc. | 17.20M | -1.48% | 110,784 | 11.65M |
| 515 | CLRB | Cellectar Biosciences, Inc. | 16.62M | -1.51% | 35,601 | - |
| 516 | ABP | Abpro Holdings, Inc. | 16.13M | 6.26% | 20,165 | 183.00K |
| 517 | SNGX | Soligenix, Inc. | 16.04M | 0.63% | 109,760 | 2.34K |
| 518 | CMMB | Chemomab Therapeutics Ltd. | 16.00M | -5.11% | 160,495 | - |
| 519 | PULM | Pulmatrix, Inc. | 15.96M | 8.98% | 6,051 | 3.00K |
| 520 | ATHA | Athira Pharma, Inc. | 15.81M | 3.35% | 12,026 | - |
| 521 | CANF | Can-Fite BioPharma Ltd. | 15.80M | -3.06% | 807,053 | 560.00K |
| 522 | TPST | Tempest Therapeutics, Inc. | 15.77M | 2.89% | 83,443 | - |
| 523 | KALA | KALA BIO, Inc. | 15.59M | -6.23% | 2,305,127 | - |
| 524 | BCDA | BioCardia, Inc. | 15.39M | 1.40% | 46,552 | 3.00K |
| 525 | COCP | Cocrystal Pharma, Inc. | 14.61M | 0.95% | 43,386 | - |
| 526 | LGVN | Longeveron Inc. | 13.87M | 9.63% | 379,310 | 1.44M |
| 527 | DWTX | Dogwood Therapeutics, Inc. | 13.78M | 0.17% | 32,732 | - |
| 528 | BLRX | BioLineRx Ltd. | 13.76M | -2.11% | 30,920 | 12.74M |
| 529 | MBRX | Moleculin Biotech, Inc. | 13.50M | -8.55% | 2,372,100 | - |
| 530 | ICU | SeaStar Medical Holding Corporation | 12.85M | 5.10% | 732,334 | 881.00K |
| 531 | EDSA | Edesa Biotech, Inc. | 12.60M | 2.87% | 40,747 | - |
| 532 | AKTX | Akari Therapeutics, Plc | 12.54M | 3.24% | 6,053,745 | - |
| 533 | VYNE | VYNE Therapeutics Inc. | 12.54M | 0.80% | 526,782 | 524.00K |
| 534 | PHIO | Phio Pharmaceuticals Corp. | 12.38M | 1.77% | 696,645 | - |
| 535 | SYBX | Synlogic, Inc. | 12.23M | 0.48% | 57,423 | 8.00K |
| 536 | IMNN | Imunon, Inc. | 12.19M | 1.79% | 24,983 | - |
| 537 | GOVX | GeoVax Labs, Inc. | 11.82M | -3.47% | 644,388 | 3.35M |
| 538 | BIVI | BioVie Inc. | 11.68M | -2.52% | 81,331 | - |
| 539 | BOLT | Bolt Biotherapeutics, Inc. | 11.27M | 9.31% | 65,897 | 5.20M |
| 540 | CLDI | Calidi Biotherapeutics, Inc. | 11.12M | 3.40% | 72,691 | - |
| 541 | IMRN | Immuron Limited | 11.09M | 2.72% | 557,418 | 4.78M |
| 542 | PPCB | Propanc Biopharma, Inc. | 10.83M | -3.16% | 21,016 | - |
| 543 | APM | Aptorum Group Limited | 10.75M | -0.38% | 26,331 | - |
| 544 | ERNA | Ernexa Therapeutics Inc. | 10.67M | 4.62% | 48,804 | 1,000.00 |
| 545 | QNRX | Quoin Pharmaceuticals, Ltd. | 10.41M | -17.54% | 173,049 | - |
| 546 | SNSE | Sensei Biotherapeutics, Inc. | 10.05M | -3.28% | 57,791 | - |
| 547 | ASBP | Aspire Biopharma Holdings, Inc. | 9.73M | -0.55% | 8,136,661 | 1.94K |
| 548 | EVGN | Evogene Ltd. | 9.70M | -5.22% | 61,640 | 8.02M |
| 549 | SLXN | Silexion Therapeutics Corp | 9.57M | -0.33% | 22,290 | - |
| 550 | BRTX | BioRestorative Therapies, Inc. | 9.50M | -0.93% | 17,228 | 383.40K |
| 551 | MBIO | Mustang Bio, Inc. | 9.20M | 0.80% | 171,397 | - |
| 552 | TCRT | Alaunos Therapeutics, Inc. | 8.90M | -2.44% | 125,955 | 6.00K |
| 553 | ACXP | Acurx Pharmaceuticals, Inc. | 8.84M | -4.29% | 79,485 | - |
| 554 | AEON | AEON Biopharma, Inc. | 8.57M | -4.80% | 61,697 | - |
| 555 | ALZN | Alzamend Neuro, Inc. | 8.25M | -3.56% | 42,189 | - |
| 556 | XTLB | XTL Biopharmaceuticals Ltd. | 8.20M | 3.13% | 16,526 | 451.00K |
| 557 | CELZ | Creative Medical Technology Holdings, Inc. | 8.10M | -1.35% | 28,595 | 6.00K |
| 558 | GRDX | GridAI Technologies Corp. | 8.08M | 0.54% | 21,981 | - |
| 559 | BGMS | Bio Green Med Solution, Inc. | 7.99M | -4.96% | 25,494 | 81.00K |
| 560 | INAB | IN8bio, Inc. | 7.88M | -4.49% | 40,675 | - |
| 561 | ADXN | Addex Therapeutics Ltd | 7.81M | -5.78% | 3,162 | 198.82K |
| 562 | RNAZ | TransCode Therapeutics, Inc. | 7.71M | 0.72% | 14,305 | - |
| 563 | KPRX | Kiora Pharmaceuticals, Inc. | 7.56M | -0.48% | 28,760 | 20.00K |
| 564 | PMCB | PharmaCyte Biotech, Inc. | 7.54M | -3.48% | 1,756,530 | - |
| 565 | TOVX | Theriva Biologics, Inc. | 7.52M | 0.81% | 1,269,669 | - |
| 566 | ADIL | Adial Pharmaceuticals, Inc. | 7.39M | 1.15% | 241,014 | - |
| 567 | GNPX | Genprex, Inc. | 7.36M | -4.42% | 176,775 | - |
| 568 | CDIO | Cardio Diagnostics Holdings, Inc. | 7.03M | 7.54% | 63,894 | 15.78K |
| 569 | LYRA | Lyra Therapeutics, Inc. | 7.03M | -0.25% | 35,188 | 600.00K |
| 570 | PPBT | Purple Biotech Ltd | 6.91M | 1.84% | 84,716 | - |
| 571 | GTBP | GT Biopharma, Inc. | 6.81M | -1.45% | 812,949 | - |
| 572 | GLMD | Galmed Pharmaceuticals Ltd. | 6.36M | -4.13% | 224,240 | - |
| 573 | CYCN | Cyclerion Therapeutics, Inc. | 6.32M | -1.78% | 11,223 | 2.86M |
| 574 | REVB | Revelation Biosciences, Inc. | 6.28M | 0.47% | 74,071 | - |
| 575 | VIVS | VivoSim Labs, Inc. | 6.15M | -1.26% | 13,148 | 140.00K |
| 576 | SILO | Silo Pharma, Inc. | 5.89M | -2.75% | 97,638 | 72.10K |
| 577 | APRE | Aprea Therapeutics, Inc. | 5.85M | -10.80% | 230,159 | 488.24K |
| 578 | XBIO | Xenetic Biosciences, Inc. | 5.64M | 0.94% | 15,716 | 2.86M |
| 579 | MTNB | Matinas BioPharma Holdings, Inc. | 5.39M | -5.93% | 19,939 | - |
| 580 | HCWB | HCW Biologics Inc. | 5.19M | -2.54% | 24,022 | 422.03K |
| 581 | ENSC | Ensysce Biosciences, Inc. | 5.16M | -11.25% | 5,958,669 | 4.49M |
| 582 | SLRX | Salarius Pharmaceuticals, Inc. | 4.87M | 0.10% | 180,902 | - |
| 583 | JAGX | Jaguar Health, Inc. | 4.79M | 6.36% | 171,553 | 11.79M |
| 584 | INDP | Indaptus Therapeutics, Inc. | 4.55M | -0.38% | 165,262 | - |
| 585 | GRI | GRI Bio, Inc. | 4.54M | 2.96% | 927,759 | - |
| 586 | CNSP | CNS Pharmaceuticals, Inc. | 4.34M | -3.00% | 5,635 | - |
| 587 | ONCO | Onconetix, Inc. | 4.33M | -1.01% | 10,149 | 1.22M |
| 588 | XRTX | XORTX Therapeutics Inc. | 4.21M | -2.19% | 18,096 | - |
| 589 | OGEN | Oragenics, Inc. | 4.11M | 0.94% | 87,345 | - |
| 590 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.07M | -1.84% | 72,265 | 1.36M |
| 591 | AZTR | Azitra, Inc. | 4.05M | -1.82% | 111,002 | 7.50K |
| 592 | SCNI | Scinai Immunotherapeutics Ltd. | 3.95M | 4.20% | 94,946 | 1.15M |
| 593 | ARTL | Artelo Biosciences, Inc. | 3.75M | 3.33% | 111,055 | - |
| 594 | PHGE | BiomX Inc. | 3.73M | -25.15% | 260,227 | - |
| 595 | SPRC | SciSparc Ltd. | 3.63M | 11.44% | 701,856 | 1.31M |
| 596 | ENVB | Enveric Biosciences, Inc. | 3.53M | -2.47% | 2,973,721 | - |
| 597 | ELAB | PMGC Holdings Inc. | 3.27M | -11.13% | 314,764 | 285.95K |
| 598 | PTIX | Protagenic Therapeutics, Inc. | 3.13M | -1.82% | 564,358 | - |
| 599 | VRAX | Virax Biolabs Group Limited | 3.07M | -11.32% | 1,130,735 | 2.99K |
| 600 | DRMA | Dermata Therapeutics, Inc. | 2.98M | 4.69% | 194,752 | - |
| 601 | PBM | Psyence Biomedical Ltd. | 2.98M | -5.92% | 15,425,776 | - |
| 602 | CDT | CDT Equity Inc. | 2.88M | -10.15% | 265,805 | - |
| 603 | BDRX | Biodexa Pharmaceuticals Plc | 2.52M | -53.75% | 907,144 | 104.90K |
| 604 | CMND | Clearmind Medicine Inc. | 2.51M | -3.03% | 5,259,171 | - |
| 605 | MLEC | Moolec Science SA | 1.80M | 4.37% | 16,648 | 7.83M |
| 606 | ADTX | Aditxt, Inc. | 1.77M | -2.46% | 894,272 | 5.95K |